Philippe Perron Savard

This profile gathers the share dealings of Philippe Perron Savard in Acerus Pharmaceuticals Corporation. Between 7 December 2018 and 6 May 2022, the trades on record add up to 3 filings.

Purchases make up the whole of the open-market record (1 purchase, €1,258). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The newest entry dates from 6 May 2022: a transaction, in Acerus Pharmaceuticals Corporation. The latest purchase dates back some time: it was published 2,880 days ago, on 7 December 2018. Half of the filings or more reach the SEDI feed on the day of the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.